Ischemic Cardiovascular Disease in Persons with Human Immunodeficiency Virus Infection
Open Access
- 1 January 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 34 (1), 98-102
- https://doi.org/10.1086/324745
Abstract
Persons with human immunodeficiency virus (HIV) infection might be at risk for ischemic cardiovascular disease (CVD). We reviewed the records of 16 HIV-infected persons with proven CVD (8 cases of angina and 8 cases of myocardial infarctions). This represents 1.7% of HIV-infected persons seen at our institution from 1 April 1999 through 25 April 2000. In comparison with 32 HIV-infected age- and sex-matched controls, case patients had more risk factors for CVD (median number of risk factors for CVD, 3 versus 1; P > .001), lower nadir CD4+ lymphocyte counts (median, 101 cells/mm3 versus 278 cells/mm3; P = .02), and a longer duration of prior exposure to nucleoside analogs (median, 190 weeks versus 130 weeks; P = .02). There was no difference in the duration of exposure to protease inhibitors. Ischemic CVD occurs in HIV-infected persons and appears to be most closely associated with traditional risk factors for coronary artery disease (for example, hypertension and hypercholesterolemia). Lower CD4+ lymphocyte counts and duration of HIV infection might also be risk factors or markers for the development of ischemic CVD.Keywords
This publication has 12 references indexed in Scilit:
- Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and LipodystrophyClinical Infectious Diseases, 2001
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Hyperlipidemia under treatment with proteinase inhibitorsInfection, 1999
- HIV protease inhibitors: advances in therapy and adverse reactions, including metabolic complications.Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Primary Prevention of Coronary Heart Disease: Guidance From FraminghamCirculation, 1998
- Severe premature coronary artery disease with protease inhibitorsThe Lancet, 1998
- 5.9 HIV‐related cardiovascular diseaseThe Medical Journal of Australia, 1996
- Mycarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virusJournal of the American College of Cardiology, 1994
- Cardiac complications in acquired immunodeficiency syndrome (AIDS): A reviewJournal of the American College of Cardiology, 1989